EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Omics‐Driven Machine Learning Path to Cost‐Effective Precision Medicine in Chronic Kidney Disease

Marta B Lopes iD, Roberta Coletti, Flore Duranton iD, Griet Glorieux, Mayra Alejandra Jaimes Campos, Julie Klein, Matthias Ley, Paul Perco iD, Alexia Sampri, Aviad Tur-Sinai

PROTEOMICS · 2025-06 · 25 (11-12)

DOI: 10.1002/pmic.202400108 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PROTEOMICS, online erschienen am 10.01.2025. Verfasst von Marta B Lopes und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mathematics and Applications (NOVA Math), NOVA School of Science and Technology (NOVA FCT), Caparica, Portugal. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Precision Medicine, Machine Learning, Proteomics. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Österreichische Forschungsförderungsgesellschaft, European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) poses a significant and growing global health challenge, making early detection and slowing disease progression essential for improving patient outcomes. Traditional diagnostic methods such as glomerular filtration rate and proteinuria are insufficient to capture the complexity of CKD. In contrast, omics technologies have shed light on the molecular mechanisms of CKD, helping to identify biomarkers for disease assessment and management. Artificial intelligence (AI) and machine learning (ML) could transform CKD care, enabling biomarker discovery for early diagnosis and risk prediction, and personalized treatment. By integrating multi‐omics datasets, AI can provide real‐time, patient‐specific insights, improve decision support, and optimize cost efficiency by early detection and avoidance of unnecessary treatments. Multidisciplinary collaborations and sophisticated ML methods are essential to advance diagnostic and therapeutic strategies in CKD. This review presents a comprehensive overview of the pipeline for translating CKD omics data into personalized treatment, covering recent advances in omics research, the role of ML in CKD, and the critical need for clinical validation of AI‐driven discoveries to ensure their efficacy, relevance, and cost‐effectiveness in patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicPrecision MedicineMachine LearningProteomicsHumansCost-Benefit AnalysisBiomarkersGenomics

Stichwörter der Autor:innen

artificial intelligencechronic kidney diseasecost‐effectivenessmachine learningmulti‐omics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Center for Mathematics and Applications (NOVA Math), NOVA School of Science and Technology (NOVA FCT), Caparica, Portugal.
  • UNIDEMI, Department of Mechanical and Industrial Engineering, NOVA School of Science and Technology (NOVA FCT), Caparica, Portugal.
  • RD-Néphrologie, Montpellier, France.
  • Department of Internal Medicine and Pediatrics, Nephrology Unit, Ghent University Hospital, Gent, Belgium.
  • Department of Biomarker Research, Mosaiques Diagnostics GmbH, Hannover, Germany.
  • Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Aachen, Germany.

ORCID-Profile: Marta B Lopes, Flore Duranton, Paul Perco

Förderung

  • Fundação para a Ciência e a Tecnologia
  • Österreichische Forschungsförderungsgesellschaft
  • European Cooperation in Science and Technology
  • Wellcome Trust
  • Horizon Europe Marie Skłodowska-Curie Action Doctoral Network

Zitieren

APA

Lopes, M. B., Coletti, R., Duranton, F., Glorieux, G., Jaimes Campos, M. A., Klein, J., Ley, M., Perco, P., Sampri, A., & Tur-Sinai, A. (2025). The Omics‐Driven Machine Learning Path to Cost‐Effective Precision Medicine in Chronic Kidney Disease. PROTEOMICS, 25(11-12). https://doi.org/10.1002/pmic.202400108

Vancouver

Lopes MB, Coletti R, Duranton F, Glorieux G, Jaimes Campos MA, Klein J, et al. The Omics‐Driven Machine Learning Path to Cost‐Effective Precision Medicine in Chronic Kidney Disease. PROTEOMICS. 2025;25(11-12). doi:10.1002/pmic.202400108

BibTeX
@article{Lopes2025,
  author = {Lopes, Marta B and Coletti, Roberta and Duranton, Flore and Glorieux, Griet and Jaimes Campos, Mayra Alejandra and Klein, Julie and Ley, Matthias and Perco, Paul and Sampri, Alexia and Tur-Sinai, Aviad},
  title = {The Omics‐Driven Machine Learning Path to Cost‐Effective Precision Medicine in Chronic Kidney Disease},
  journal = {PROTEOMICS},
  year = {2025},
  volume = {25},
  number = {11-12},
  doi = {10.1002/pmic.202400108}
}
Kostenlos starten →